CNS Pharmaceuticals (CNSP) Short Interest Ratio & Short Volume $1.30 -0.02 (-1.52%) Closing price 03/28/2025 04:00 PM EasternExtended Trading$1.21 -0.09 (-6.92%) As of 03/28/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock CNS Pharmaceuticals Short Interest DataCNS Pharmaceuticals (CNSP) has a short interest of 180,100 shares, representing 6.17% of the float (the number of shares available for trading by the public). This marks a -32.92% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.3, indicating that it would take 0.3 days of the average trading volume of 275,703 shares to cover all short positions.Current Short Interest180,100 sharesPrevious Short Interest268,500 sharesChange Vs. Previous Month-32.92%Dollar Volume Sold Short$561,912.00Short Interest Ratio0.3 Days to CoverLast Record DateMarch 15, 2025Outstanding Shares2,944,000 sharesFloat Size2,920,000 sharesShort Percent of Float6.17%Today's Trading Volume161,488 sharesAverage Trading Volume275,703 sharesToday's Volume Vs. Average59% Short Selling CNS Pharmaceuticals? Sign up to receive the latest short interest report for CNS Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCNSP Short Interest Over TimeCNSP Days to Cover Over TimeCNSP Percentage of Float Shorted Over Time Remove Ads CNS Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/15/2025180,100 shares $561,912.00 -32.9%6.2%0.3 $3.12 2/28/2025268,500 shares $652,455.00 +241.6%9.9%0.5 $2.43 2/15/202578,600 shares $550,200.00 -97.8%5.2%0.1 $7.00 1/31/20253,630,000 shares $345,213.00 -19.9%N/A0.2 $0.10 1/15/20254,530,000 shares $498,300.00 +861.6%N/A0.2 $0.11 12/31/2024471,100 shares $56,720.44 -64.8%N/A0 $0.12 12/15/20241,340,000 shares $137,886.00 -35.3%N/A0.1 $0.10 11/30/20242,070,000 shares $231,840.00 +202.9%N/A0.1 $0.11 11/15/2024683,300 shares $71,814.83 -40.1%N/A0 $0.11 10/31/20241,140,000 shares $127,224.00 +2.7%N/A0.1 $0.11 Get the Latest News and Ratings for CNSP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for CNS Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 10/15/20241,110,000 shares $137,862.00 +63.5%N/A0.1 $0.12 9/30/2024679,000 shares $88,609.50 +86.2%N/A0.1 $0.13 9/15/2024364,600 shares $54,033.72 +80.1%N/A0.1 $0.15 8/31/2024202,500 shares $31,833.00 +87.7%N/A0 $0.16 8/15/2024107,900 shares $15,213.90 -90.3%N/A0 $0.14 7/31/20241,110,000 shares $351,648.00 +314.3%40.1%0.3 $0.32 7/15/2024267,900 shares $316,122.00 +229.9%9.7%0.2 $1.18 6/30/202481,200 shares $128,296.00 +29.7%5.8%0.1 $1.58 6/15/202462,600 shares $174,654.00 +1,465.0%27.3%0.2 $2.79 5/31/20244,000 shares $43,240.00 -93.6%1.8%0.2 $10.81 5/15/202462,500 shares $12,006.25 +100.3%0.6%0.2 $0.19 4/30/202431,200 shares $6,552.00 +35.1%0.3%0.1 $0.21 4/15/202423,100 shares $5,530.14 -53.8%0.2%0.1 $0.24 3/31/202450,000 shares $18,100.00 -51.8%0.5%0.1 $0.36 3/15/2024103,800 shares $36,983.94 +91.5%1.3%0.3 $0.36 2/29/202454,200 shares $15,067.60 -47.2%0.7%0.1 $0.28 2/15/2024102,600 shares $29,035.80 -87.2%1.3%0.3 $0.28 1/31/2024802,400 shares $198,995.20 +317.1%10.2%2.6 $0.25 1/15/2024192,400 shares $179,894.00 -10.8%3.1%1.6 $0.94 12/31/2023215,700 shares $273,939.00 +298.0%3.5%2.1 $1.27 12/15/202354,200 shares $93,766.00 +30.6%0.9%0.5 $1.73 11/30/202341,500 shares $86,320.00 +75.1%0.8%0.6 $2.08 11/15/202323,700 shares $45,504.00 -50.3%0.5%0.3 $1.92 10/31/202347,700 shares $98,739.00 -36.6%1.2%0.3 $2.07 10/15/202375,200 shares $101,520.00 +22.7%1.8%0.5 $1.35 9/30/202361,300 shares $69,882.00 -8.5%1.5%0.5 $1.14 9/15/202367,000 shares $100,500.00 -45.2%1.6%0.4 $1.50 8/31/2023122,300 shares $209,133.00 +69.6%3.0%0.6 $1.71 8/15/202372,100 shares $123,291.00 -3.1%1.8%0.2 $1.71 7/31/202374,400 shares $168,144.00 +11.4%1.8%0.2 $2.26Game Over for Tesla? (Ad)Tesla is down 50% from its high... Our research indicates investors are waking up to the fact that Tesla is no longer Musk's #1 priority. His real goal is political power - and his private AI firm xAI. He recently bought over $1 billion worth of AI chips from NVIDIA... And is about to spend $5 billion on yet another data center for xAI.While Tesla keeps tanking, Elon's secretive AI venture is growing 7X faster than its main competitor 7/15/202366,800 shares $142,952.00 -70.0%1.6%0 $2.14 6/30/2023222,600 shares $496,398.00 +7.2%5.5%0.1 $2.23 6/15/2023207,600 shares $448,416.00 -9.4%5.1%0.1 $2.16 5/31/2023229,100 shares $421,544.00 +91.6%5.7%0.1 $1.84 5/15/2023119,600 shares $166,244.00 -44.6%3.0%0 $1.39 4/30/2023215,800 shares $325,858.00 +306.4%10.0%0.1 $1.51 4/15/202353,100 shares $124,785.00 +410.6%3.1%0 $2.35 3/31/202310,400 shares $10,400.00 -57.6%0.6%0 $1.00 3/15/202324,500 shares $30,380.00 +49.4%2.3%0.6 $1.24 2/28/202316,400 shares $30,340.00 +62.4%1.6%0.4 $1.85 2/15/202310,100 shares $17,372.00 +206.1%1.0%0.3 $1.72 1/31/20233,300 shares $7,293.00 +153.9%0.3%0.1 $2.21 1/15/20231,300 shares $3,120.00 -63.9%0.1%0.1 $2.40 12/30/20223,600 shares $8,640.00 -65.4%0.3%0.2 $2.40 12/15/202210,400 shares $26,520.00 -2.8%0.8%0.6 $2.55 11/30/202210,700 shares $32,421.00 -88.5%1.1%0.7 $3.03 11/15/202293,200 shares $17,717.32 +24.4%N/A0.5 $0.19 10/31/202274,900 shares $11,984.00 +21.2%N/A0.4 $0.16 10/15/202261,800 shares $12,656.64 -65.7%N/A0.3 $0.20 9/30/2022180,000 shares $32,220.00 -14.6%N/A0.7 $0.18 9/15/2022210,800 shares $51,856.80 +15.0%N/A0.4 $0.25 8/31/2022183,300 shares $44,798.52 -1.6%N/A0.3 $0.24 8/15/2022186,200 shares $48,207.18 +17.7%N/A0.3 $0.26 7/31/2022158,200 shares $34,756.54 +870.6%N/A0.3 $0.22 7/15/202216,300 shares $4,401.00 -95.0%N/A0 $0.27 6/30/2022325,800 shares $91,224.00 +15.4%N/A0.4 $0.28 6/15/2022282,400 shares $77,010.48 -46.6%N/A0.3 $0.27 5/31/2022528,500 shares $160,241.20 +80.6%N/A0.6 $0.30 5/15/2022292,600 shares $84,854.00 -19.7%N/A0.2 $0.29 4/30/2022364,500 shares $123,201.00 -9.5%N/A0.2 $0.34 4/15/2022402,800 shares $157,092.00 +1,154.8%N/A0.3 $0.39 3/31/202232,100 shares $10,946.10 -89.0%N/A0 $0.34 3/15/2022291,000 shares $93,120.00 -46.3%1.6%0.2 $0.32 2/28/2022541,900 shares $211,341.00 +41.6%3.1%0.4 $0.39 2/15/2022382,700 shares $133,945.00 -69.9%2.2%0.5 $0.35 1/31/20221,270,000 shares $763,270.00 +8.6%7.2%1.7 $0.60 1/15/20221,170,000 shares $895,050.00 +353.7%6.6%1.6 $0.77 12/31/2021257,900 shares $181,148.96 +8.8%1.5%0.4 $0.70 12/15/2021237,000 shares $218,182.20 -21.5%1.4%1.1 $0.92 11/30/2021301,800 shares $338,016.00 +16.1%1.7%1.4 $1.12 11/15/2021260,000 shares $293,800.00 -19.7%1.5%1.3 $1.13 10/29/2021323,900 shares $446,982.00 -10.8%1.9%2.2 $1.38 10/15/2021363,200 shares $533,904.00 -2.6%2.1%2.7 $1.47 9/30/2021373,000 shares $555,770.00 -16.9%2.2%2.1 $1.49 9/15/2021448,700 shares $695,485.00 +6.9%2.6%0.9 $1.55 8/31/2021419,600 shares $713,320.00 0.0%2.6%0.8 $1.70 8/13/2021419,700 shares $700,899.00 -3.9%2.6%0.8 $1.67 7/30/2021436,900 shares $751,468.00 -28.0%2.9%0.9 $1.72 7/15/2021607,000 shares $1.09 million +57.5%4.0%1.2 $1.80 6/30/2021385,400 shares $755,384.00 +30.4%2.6%0.8 $1.96Game Over for Tesla? (Ad)Tesla is down 50% from its high... Our research indicates investors are waking up to the fact that Tesla is no longer Musk's #1 priority. His real goal is political power - and his private AI firm xAI. He recently bought over $1 billion worth of AI chips from NVIDIA... And is about to spend $5 billion on yet another data center for xAI.While Tesla keeps tanking, Elon's secretive AI venture is growing 7X faster than its main competitor 6/15/2021295,600 shares $588,244.00 +1.2%2.0%1.9 $1.99 5/28/2021292,100 shares $540,385.00 -12.7%1.9%1.3 $1.85 5/14/2021334,400 shares $571,824.00 +11.1%2.2%1.2 $1.71 4/30/2021300,900 shares $616,845.00 -4.2%2.0%0.5 $2.05 4/15/2021314,100 shares $669,033.00 -17.0%2.1%0.2 $2.13 3/31/2021378,400 shares $877,888.00 -26.9%2.5%0.2 $2.32 3/15/2021517,400 shares $1.38 million -1.4%3.4%0.2 $2.67 2/26/2021524,900 shares $1.51 million +0.8%3.5%0.2 $2.88 2/12/2021520,600 shares $1.92 million +688.8%3.6%0.2 $3.68 1/29/202166,000 shares $119,460.00 -53.2%0.5%0 $1.81 1/15/2021140,900 shares $264,892.00 +13.7%1.0%0.1 $1.88 12/31/2020123,900 shares $219,303.00 +89.7%0.9%0.1 $1.77 12/15/202065,300 shares $158,679.00 -4.3%0.9%0.1 $2.43 11/30/202068,200 shares $163,680.00 -15.0%1.0%1.4 $2.40 11/15/202080,200 shares $170,024.00 +6.5%1.2%1.1 $2.12 10/30/202075,300 shares $134,787.00 -1.3%1.2%0.8 $1.79 10/15/202076,300 shares $144,970.00 -10.7%1.2%0.8 $1.90 9/30/202085,400 shares $150,304.00 -5.6%1.3%0.8 $1.76 9/15/202090,500 shares $177,380.00 -25.6%1.4%0.9 $1.96 8/31/2020121,700 shares $261,655.00 +32.4%1.9%0.9 $2.15 8/14/202091,900 shares $162,663.00 -9.6%1.4%0.9 $1.77 7/31/2020101,600 shares $188,976.00 +19.0%1.6%1.4 $1.86 7/15/202085,400 shares $146,888.00 -15.1%1.3%1.2 $1.72 6/30/2020100,600 shares $215,284.00 -30.6%1.6%0.7 $2.14 6/15/2020144,900 shares $357,903.00 +45.6%2.2%1 $2.47 5/29/202099,500 shares $238,800.00 +22.4%1.5%0.8 $2.40 5/15/202081,300 shares $224,388.00 +4.9%1.3%0.5 $2.76 4/30/202077,500 shares $222,425.00 -29.7%1.2%0.5 $2.87 4/15/2020110,200 shares $360,354.00 +106.8%1.7%0.7 $3.27 3/31/202053,300 shares $148,707.00 -43.0%0.8%0.3 $2.79 CNSP Short Interest - Frequently Asked Questions What is CNS Pharmaceuticals' current short interest? Short interest is the volume of CNS Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of March 15th, investors have sold 180,100 shares of CNSP short. 6.17% of CNS Pharmaceuticals' shares are currently sold short. Learn More on CNS Pharmaceuticals' current short interest. What is a good short interest percentage for CNS Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.17% of CNS Pharmaceuticals' floating shares are currently sold short. Is CNS Pharmaceuticals' short interest increasing or decreasing? CNS Pharmaceuticals saw a decrease in short interest during the month of March. As of March 15th, there was short interest totaling 180,100 shares, a decrease of 32.9% from the previous total of 268,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is CNS Pharmaceuticals' float size? CNS Pharmaceuticals currently has issued a total of 2,944,000 shares. Some of CNS Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. CNS Pharmaceuticals currently has a public float of 2,920,000 shares. How does CNS Pharmaceuticals' short interest compare to its competitors? 6.17% of CNS Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to CNS Pharmaceuticals: Synlogic, Inc. (0.74%), Leap Therapeutics, Inc. (5.39%), NeuroSense Therapeutics Ltd. (1.41%), Incannex Healthcare Inc. (0.36%), Affimed (4.63%), Marker Therapeutics, Inc. (4.99%), Spruce Biosciences, Inc. (0.71%), HCW Biologics Inc. (1.70%), ImmunoPrecise Antibodies Ltd. (14.01%), Citius Pharmaceuticals, Inc. (6.39%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($26.28 billion), iShares 20+ Year Treasury Bond ETF ($9.53 billion), MicroStrategy Incorporated ($8.50 billion), Apollo Global Management, Inc. ($4.86 billion), Super Micro Computer, Inc. ($4.85 billion), Charter Communications, Inc. ($4.28 billion), Capital One Financial Co. ($4.08 billion), AppLovin Co. ($3.82 billion), Canadian Natural Resources Limited ($3.78 billion), and Schlumberger Limited ($2.87 billion). View all of the most shorted stocks. What does it mean to sell short CNS Pharmaceuticals stock? Short selling CNSP is an investing strategy that aims to generate trading profit from CNS Pharmaceuticals as its price is falling. CNSP shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against CNS Pharmaceuticals? A short squeeze for CNS Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CNSP, which in turn drives the price of the stock up even further. How often is CNS Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CNSP, twice per month. The most recent reporting period available is March, 15 2025. More Short Interest Resources from MarketBeat Related Companies Synlogic Short Interest Data Leap Therapeutics Short Interest Data NeuroSense Therapeutics Short Interest Data Incannex Healthcare Short Interest Data Affimed Short Interest Data Marker Therapeutics Short Interest Data Spruce Biosciences Short Interest Data HCW Biologics Short Interest Data ImmunoPrecise Antibodies Short Interest Data Citius Pharmaceuticals Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CNSP) was last updated on 3/31/2025 by MarketBeat.com Staff From Our PartnersA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CNS Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CNS Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CNSP Stock Free CNSP Stock Alerts